Stomach Cancer Prevention and Early Detection Act
Summary
What This Bill Does
The Stomach Cancer Prevention and Early Detection Act responds to an estimated 30,300 new U.S. stomach cancer cases in 2025 and disparities in incidence and mortality by race and ethnicity. NCI must review national incidence, risk factors among high-risk populations and the general public, optimal age ranges for Helicobacter pylori testing and treatment, screening availability and effectiveness, endoscopic screening, endoscopic resection and surveillance for gastric intestinal metaplasia with high-grade dysplasia and early gastric cancer, surveillance for elevated-risk patients with family history, ethnicity, smoking, or H. pylori risk, public awareness, provider education, and federal awareness efforts. Within 18 months, NCI must report recommendations on defining high-risk populations, identifying high-risk individuals, detecting precancerous lesions and early cancer, routine screening guidelines, and improvements in research, prevention, early diagnosis, screening, and treatment. DOD, coordinating with NCI and CDC, must separately study stomach cancer among service members and veterans, including burn pits, hazardous chemicals, contaminated water, occupational hazards, endemic H. pylori, disparities by military characteristics, screening in military and VA health systems, and integration of prevention and screening protocols.
Who Benefits and How
High-risk stomach cancer patients benefit if NCI recommendations lead to clearer screening and early detection practices. Racial and ethnic groups with higher stomach cancer burden benefit from focused analysis of incidence, mortality, risk factors, and awareness gaps. Military personnel and veterans benefit from a DOD study of service-related stomach cancer risks and screening opportunities. Cancer researchers benefit from federal reports that define high-risk populations and research priorities for prevention and early diagnosis.
Who Bears the Burden and How
National Cancer Institute staff must conduct the review and issue recommendations within 18 months. Defense Department health offices must study stomach cancer incidence, risk factors, and prevention among current and former service members. CDC cancer experts must coordinate with DOD and NCI on the military stomach cancer study. Military health system administrators may need to evaluate screening and treatment protocols after the report.
Key Provisions
- Requires an NCI review of stomach cancer incidence, risk factors, screening, H. pylori, awareness, and federal efforts.
- Requires NCI recommendations on high-risk population definitions, early detection, routine screening, research, prevention, and treatment.
- Requires a DOD study of stomach cancer incidence, mortality, deployment risks, disparities, and screening among service members and veterans.
- Requires reports to Congress within 18 months.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Requires the National Cancer Institute to review stomach cancer incidence, risk factors, Helicobacter pylori testing and treatment, screening, endoscopic surveillance, awareness, education, and federal efforts, report recommendations within 18 months, and requires the Defense Department, with NCI and CDC, to study stomach cancer incidence and service-related risk factors among active-duty and former military personnel.
Key Policy Areas
Cancer Research, Public Health, Military Health
Primary Purpose
Requires the National Cancer Institute to review stomach cancer incidence, risk factors, Helicobacter pylori testing and treatment, screening, endoscopic surveillance, awareness, education, and federal efforts, report recommendations within 18 months, and requires the Defense Department, with NCI and CDC, to study stomach cancer incidence and service-related risk factors among active-duty and former military personnel.
Policy Domains
Resolution provisions
Identified Gains
- High-risk stomach cancer patients
- Racial health disparity communities
- Military personnel
- Cancer researchers
Identified Costs
- National Cancer Institute staff
- Defense health offices
- CDC cancer experts
- Military health administrators
Sponsors
Legislative Progress
In CommitteeReferred to the Subcommittee on Health.
Ms. Chu (for herself and Mr. Wilson of South Carolina) …
Referred to the Committee on Energy and Commerce, and in …
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
CDC cancer experts, National Cancer Institute staff
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology